A recent report published by
Infinium Global Research on the immunotherapy drugs market provides an in-depth
analysis of segments and sub-segments in the global as well as regional
immunotherapy drugs market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional immunotherapy drugs
market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecasts, and dollar values of the global immunotherapy
drugs market. According to the report, the global immunotherapy drugs market is
projected to grow at a CAGR of 10.5% over the forecast period of 2022-2028.
The revenue generated by the immunotherapy drugs market was approximately USD 209 billion in 2022 and is expected
to reach approximately USD 380 billion in 2028. and is expected to grow with a
CAGR of more than 10.5% by 2028. Immunotherapy is a biological therapy, which
harnesses the ability of the immune system of a human body for combating a
disease or an infection. Immunotherapy techniques either involve stimulation of the immune system to work smarter against the attack of cancer cells or induction
of artificial immune system proteins or some other immune system components to
improve immunity. Immunotherapy is an alternative treatment for multiple
types of cancers such as brain, bladder, breast, cervical, colorectal, gastric,
kidney, lymphoma, leukemia, lung, ovarian, prostate, and melanoma. In the case
of cancer, immunotherapy helps in slowing or stopping the cancer cells' growth,
stops the spreading of cancer to other regions of the body, and stimulates the
immune system to destroy the cancer cells effectively.
The COVID-19 pandemic did not
appear to have an impact on regular immunotherapy drug prescription and
distribution practices. Telemedicine was really popular. There were no
modifications in supportive treatments, however, some doctors chose to postpone
procedures (if it was part of the patients' treatment plan). Despite the fact
that demand was mostly unaffected by the covid-19 epidemic, supply chain
interruptions hampered medicine supply and caused delays in the manufacturing of
the drugs. During the early months of the pandemic, several institutions
postponed non-urgent screening checks. There were also delays in the
development of new medications. As the world recovers from the pandemic, the
market benefits.
The global immunotherapy drugs market is
driven by an increasing number of patients with lifestyle-related illnesses and a preference for targeted therapies, which cause minimal side effects.
Immunotherapy is gaining importance as an alternative frontline treatment for
cancer patients, who are averse to the serious side effects related to chemotherapy. An increasing number of cancer patients, minimal side effects, and
increasing awareness among patients are the major factors that are expected to
drive the growth of the global immunotherapy drugs market during the forecast
period. The combination of an immune checkpoint inhibitor with the common cold
virus has led to a better immune response among some advanced melanoma
patients. The undergoing research programs related to immunotherapy are
expected to yield new drugs and effective treatments for multiple sclerosis,
mesothelioma, paralysis, and other diseases during the forecast period. The high cost involved in the manufacturing of immunotherapy drugs is a major challenge
for the major players in the market. The high cost of the immunotherapy
treatment and high depreciation related to the product cycle are the major
restraints to the growth of the global immunotherapy drugs market. Emerging markets
are expected to provide opportunities for major players in the global
immunotherapy drugs market to expand, due to the increasing demand for
alternatives to conventional cancer treatments that are very costly.
Geographically, North America is
expected to be the dominating region in the market over the forecast period.
Asia-Pacific is expected to be the fastest-growing region in the market. The North American region is the largest
immunotherapy drugs market in the world. An increasing number of patients with
autoimmune diseases, infectious diseases and cancer drive the demand for immunotherapy drugs, as reimbursement plans and insurance make various
therapies affordable for them and it drives the growth of the North-American
immunotherapy drugs market. The growing number of autoimmune disease and cancer
patients drives the growth of the European immunotherapy drugs market. Efficient
research & development for developing new drugs and the acceptance of
biosimilar immunotherapy drugs are expected to drive the growth of the European
immunotherapy drugs market during the forecast period. The presence of a large
population, an increasing number of people with lifestyle-related illnesses, and
the increasing demand for treatments with minimal side effects in countries
such as China, India, Indonesia, and other countries are expected to propel the Asia-Pacific region as the fastest-growing immunotherapy drugs market.
The report on the global immunotherapy
drugs market covers segments such as product and disease type. On the basis of
product, the sub-markets include monoclonal antibodies, checkpoint inhibitors,
vaccines, inferon’s, and others. On the basis of disease type, the sub-markets
include cancer, infectious disease, autoimmune disease, and others.
The report provides profiles of
the companies in the market such as Amgen Inc, GlaxoSmithKline PLC,
F.Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Inc,
Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb, Galena
Biopharma, and Inovio Pharmaceuticals.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the immunotherapy drugs market. Moreover, the study highlights current
market trends and provides forecasts for 2022-2028. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.
Please Choose One of them.